Gabapentin
Product Images NDC 50090-2590

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-2590). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A line graph showing mean pain score over 8 weeks, comparing placebo and Gabapentin 3600 mg/day. The x-axis is labeled weeks (baseline to 8), and the y-axis is mean pain score (0 to 10). The graph indicates a 4-week dose titration period followed by a 4-week fixed dose period, with Gabapentin showing a decreasing pain score trend compared to placebo.*

FDA Label Image

Figure2 (Figure2)

A line graph depicting mean pain score over a 7-week period comparing placebo with Gabapentin at 1800 mg/day and 2400 mg/day doses. The x-axis represents the weeks, including a 3-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10, illustrating a decrease in pain scores with Gabapentin compared to placebo over time.*

FDA Label Image

Figure3 (Figure3)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' showing results from two studies. The y-axis represents percentage responders from 0% to 100%. Study 1 compares placebo (12%) to Gabapentin 3600 mg (29%). Study 2 compares placebo (14%) to Gabapentin 1800 mg (32%) and 2400 mg (34%). Statistical significance is indicated with p-values below 0.01 and 0.001.*

FDA Label Image

Figure4 (Figure4)

A scatter plot showing difference percentages versus daily dose in mg across three studies labeled a, b, and c. The x-axis represents daily doses at 600, 900, 1200, and 1800 mg, while the y-axis represents difference percentages ranging from 2% to 22%. Study a is marked with black squares, Study b with gray squares, and Study c with white squares. Data points are plotted for each study at various dose levels with corresponding difference values.*

FDA Label Image

Lbl500902590

Gabapentin 300 mg capsules label from A-S Medication Solutions showing product NDC 50090-2590, lot number space, storage instructions to keep between 68 to 77 degrees Fahrenheit, and package size of 270 capsules. The label states each capsule contains 300 mg of gabapentin and includes a QR code and distributor information for A-S Medication Solutions in Libertyville, IL.*

FDA Label Image

Scale (Scale)

A formula image depicting creatinine clearance calculation (CLCr) used for estimating renal function, incorporating age, weight, serum creatinine levels, and a factor adjustment for female patients.*

FDA Label Image

Structuralformula (Structuralformula)

Chemical structure of gabapentin showing a cyclohexane ring bonded to an aminomethyl group (CH2NH2) and a carboxymethyl group (CH2CO2H).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.